Abstract
We generated a recombinant vesicular stomatitis virus (VSV) pseudotype (VSV Delta G*SG) by replacing the envelope G gene with the GFP gene and complementing with spike glycoprotein (S) of SARS-CoV in trans. The neutralization and infection blocking tests showed that the VSV Delta G*SG and SARS-CoV reacted similarly to SARS-CoV specific antiserum, suggesting the VSVDelta G*SG can be a safe replacement of the live SARS-CoV for neutralization test and cell-entry assay.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Chickens
-
Chlorocebus aethiops
-
Cytopathogenic Effect, Viral
-
Membrane Glycoproteins / immunology*
-
Neutralization Tests / standards
-
Neutralization Tests / veterinary
-
Rhabdoviridae Infections / immunology
-
Rhabdoviridae Infections / veterinary*
-
Safety
-
Severe acute respiratory syndrome-related coronavirus / immunology*
-
Specific Pathogen-Free Organisms
-
Spike Glycoprotein, Coronavirus
-
Vero Cells
-
Vesicular stomatitis Indiana virus / genetics
-
Vesicular stomatitis Indiana virus / immunology*
-
Viral Envelope Proteins / immunology*
Substances
-
Membrane Glycoproteins
-
Spike Glycoprotein, Coronavirus
-
Viral Envelope Proteins